e-learning
resources
Barcelona 2010
Monday, 20.09.2010
Acute lung injury: barrier properties and leukocyte activation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LSC 2010 Abstract: Genetic or pharmacologic inhibition of ATX stimulates LPS-induced pulmonary inflammation
N. Oikonomou, A. Thanassopoulou, A. Kotanidou, G. D. Prestwich, V. Aidinis (Athens, Greece; Salt Lake City, United States Of America)
Source:
Annual Congress 2010 - Acute lung injury: barrier properties and leukocyte activation
Session:
Acute lung injury: barrier properties and leukocyte activation
Session type:
Oral Presentation
Number:
2113
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Oikonomou, A. Thanassopoulou, A. Kotanidou, G. D. Prestwich, V. Aidinis (Athens, Greece; Salt Lake City, United States Of America). LSC 2010 Abstract: Genetic or pharmacologic inhibition of ATX stimulates LPS-induced pulmonary inflammation. Eur Respir J 2010; 36: Suppl. 54, 2113
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
The physiology of breathlessness
Related content which might interest you:
Oral presentation: Genetic or pharmacologic inhibition of ATX stimulates LPS-induced pulmonary inflammation
Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung
Year: 2010
cPLA2alpha inhibitor ASB14780 suppresses airway MMP-9 production and improves respiratory function in cigarette-smoke induced model
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014
Maintenance of IRF1 by MAPK inhibition: A mechanism by which DUSP1 reduces glucocorticoid inhibition of CXCL10
Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action
Year: 2016
LSC 2010 Abstract: Exogenous administration of leptin restores the skewed inflammatory response in cigarette smoke-exposed
ob/ob
mice
Source: Annual Congress 2010 - Stem cells and growth factors in lung injury
Year: 2010
AZD7624, an inhaled p38 inhibitor for COPD, attenuates lung and systemic inflammation after LPS Challenge in humans
Source: International Congress 2015 – Advances in the future treatment of COPD
Year: 2015
Synergistic effects of p38 MAPK inhibition with a corticosteroid in alveolar macrophages from corticosteroid insensitive asthma patients
Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD
Year: 2013
Inhibition of LPS-induced cytokine/chemokine production from human lung macrophages by roflumilast is enabled by autocrine PGE
2
Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics
Year: 2010
Inhibition by roflumilast
vs
cilomilast of pulmonary leukocyte accumulation and TNFα release in a rat model of LPS-induced pulmonary neutrophilia
Source: Eur Respir J 2003; 22: Suppl. 45, 107s
Year: 2003
The anti-inflammatory effects of sulforaphane are not mediated by the Nrf2 pathway
Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases
Year: 2014
Stimulation of IL-8 release in respiratory cell cultures by increasing IL1-beta concentrations: Effect of budesonide
Source: Annual Congress 2013 –Asthma: new mechanisms and markers
Year: 2013
LATE-BREAKING ABSTRACT: Roflumilast and its active metabolite inhibit LPS-induced cytokines production from human parenchymal and bronchial explants: interaction with formoterol
Source: Annual Congress 2009 - Airway cell biology
Year: 2009
LSC 2010 Abstract: Macrophages promote proliferation of lung cancer cell by activation of NF-κB
Source: Annual Congress 2010 - New insights in the pathology of lung cancer
Year: 2010
Rapamycin inhibits IL-33-induced airway inflammation
Source: Annual Congress 2011 - Asthma mechanisms
Year: 2011
LSC 2010 Abstract: Creatine supplementation upregulates chronic allergic airway inflammation and remodeling via activation of epithelial cells
Source: Annual Congress 2010 - COPD and asthma: models and human studies
Year: 2010
Role of ADAM17 in endotoxin-induced pulmonary inflammation
Source: Annual Congress 2011 - Barrier functions in sepsis and acute lung injury
Year: 2011
Inhibition of HGF secretion by pulmonary fibroblasts from IPF: involvement of PGE2
Source: Eur Respir J 2003; 22: Suppl. 45, 8s
Year: 2003
Decreased PTEN amplifies PI3K signaling and enhances pro-inflammatory cytokine release in COPD
Source: International Congress 2016 – Studies in airway cell biology
Year: 2016
LSC 2010 Abstract: Overexpression of Ang-(1-7)-fusion protein in the lungs prevents pulmonary fibrosis and accompanying pulmonary hypertension
Source: Annual Congress 2010 - Pre-clinical models of airways disease
Year: 2010
Inhibition of phosphodiesterase 4B enhances glucocorticoid-dependent gene transcription in human airway epithelial cells: Implications for the treatment of COPD
Source: Annual Congress 2013 –New drugs in respiratory medicine
Year: 2013
LSC 2010 Abstract: Acute lung inflammation in response to carbon nanoparticle exposure is augmented in the absence of NF-kB
Source: Annual Congress 2010 - Emerging mechanisms in lung injury
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept